Erasca
we believe eras is the most potent inhibitor in development | Erasca
Company
Deck Type
IPO
Sector
Industry
Deck date
July 2021
Slide
15 of 46
Related slides by other companies
AbCellera
Results
February 2022
is the most potent antibody in development against the omicron variant | AbCellera
Vincera
SPAC
September 2020
highly selective and potent inhibitor a | Vincera
Other recent decks by Erasca
See all presentations (4 decks)
Investor Presentation
January 2024
Investor Presentation
November 2023
Investor Presentation
August 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io